June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The global enteric disease testing market size was evaluated at USD 4.58 billion in 2026 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
September 2026
The celiac disease treatment market was valued at USD 879.06 million in 2026, with leading companies including Takeda Pharmaceutical Company Limited, Amgen Inc.
September 2026
The rare diseases treatment market size was estimated at USD 266.68 billion in 2026and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The global blood testing market size was estimated at USD 121.51 billion in 2026 and is projected to hit around USD 224.14 billion by 2035 with a notable CAGR of 7.06%.
September 2026
The global chronic disease management market size was estimated at USD 7.51 billion in 2026 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
September 2026
The global precision genomic testing market size is valued at USD 20.55 billion in 2026 and is expected to hit around USD 69.72 billion by 2035, growing at a CAGR of 14.57%.
September 2026
The personalized testing and supplements market size reached USD 5.61 billion in 2026, with leading personalized testing and supplements market companies including Viome Life Sciences, DSM Nutritional Products AG.
September 2026
The global adiponectin testing market size was evaluated at USD 60.56 billion in 2026 and is predicted to hit around USD 120.35 billion by 2035, growing at a CAGR of 7.93%.
September 2026
The global animal testing and ecotoxicology testing market was valued at USD 4,925.33 million in 2025. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global extractable and leachable (E&L) testing services market was valued at USD 1,113.69 million in 2025 and is expected to expand at a CAGR of 12.74% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The preclinical bioanalytical testing services market was valued at USD 1.18 billion in 2025 and is expected to expand at a CAGR of 10.80% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The minimally invasive surgical instruments market size reached USD 42.51 billion in 2026, with leading minimally invasive surgical instruments market companies including The Johns Hopkins Hospital, Apollo Hospitals Enterprise Ltd., The General Hospital Corporation.
September 2026
The global minimally invasive medical imaging market explores global forecasts, key regional dynamics and how imaging advances are reshaping minimally invasive clinical workflows
September 2026
The global endotoxin testing market size is expected to increase from USD 1.60 billion in 2026 to hit around USD 3.78 billion by 2035, growing at a CAGR of 10.05%.
September 2026
The global diagnostic testing market size reached USD 213.03 billion in 2026 and is projected to hit around USD 281.56 billion by 2035, growing at a CAGR of 3.08%.
September 2026
The global esoteric testing market size is estimated at USD 41.05 billion in 2026 and is predicted to hit around USD 100.94 billion by 2035 with a CAGR of 10.53%.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The global endocrine testing market size was estimated at USD 16.97 billion in 2026 and is expected to surge around USD 35.43 billion by 2035 with a CAGR of 8.53%
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The global respiratory disease vaccine market size was calculated at USD 103.17 billion in 2026 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The end stage renal disease market was valued at USD 174.43 billion in 2026, with end stage renal disease market leading companies including Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc.,Medtronic Plc.
September 2026
The non-invasive prenatal testing market size was USD 8.05 billion in 2026, with leading non-invasive prenatal testing market players including Genesis Genetics, Natera, Centogene, Eurofins LifeCodexx GmbH.
September 2026
The global toxicology testing services market size is estimated to surpass around USD 70.78 billion by 2035 from USD 43.55 billion in 2026, with a CAGR of 5.55%.
September 2026
The non-destructive testing (NDT) market size accounted for USD 24.59 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
September 2026
The predictive disease analytics market size reached USD 5.81 billion in 2026 and is expected to be worth around USD 23.08 billion by 2035 with a CAGR of 16.6%.
September 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2026 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com